How we invest
We start with the problem, not the pitch deck.
Method
Venture Architecture Underwriting
We do not begin by asking whether a company fits a sector label. We begin by asking whether the underlying problem is consequential enough, repeated enough and structurally difficult enough to support an important company.
Early-stage companies rarely arrive with enough conventional metrics to remove uncertainty. We therefore spend more time understanding whether the problem deserves a company in the first place.
A polished deck can make a weak problem look attractive. An unusual founder working on an important problem may initially look rough. Our process is designed to tell the difference.
This allows Capitaloud to remain thesis-driven without forcing compelling companies into artificial sector boundaries.
- 01Structural Problem
- 02Economic Consequence
- 03Infrastructure Failure
- 04Category Opportunity
- 05Product Architecture
- 06Economic Buyer
- 07Founding Capability
- 08Commercial Validation
- 09Venture-Scale Outcome
- 10Investment
Second methodology
Evidence-Gap Underwriting
Venture Architecture Underwriting asks whether this is a company worth backing. Evidence-Gap Underwriting asks a different question: We underwrite what needs to become true next.
Capitaloud identifies the specific evidence separating early conviction from institutional investability, determines whether that evidence can realistically be created with a bounded amount of capital, and decides whether the opportunity merits investment.
Where the investment case clears Capitaloud’s full underwriting process, a deal-specific investment vehicle may be structured around the opportunity.
A clear evidence gap is a starting point, not a conclusion. Capitaloud invests only where the company itself is compelling, the founder can execute, the milestone is achievable, the capital required is proportionate, the round terms are attractive, the resulting evidence is likely to matter, and the risk-adjusted outcome justifies investment.
- 01Institutional blocker
What prevents conventional institutional entry today?
- 02Evidence required
What specifically must become true?
- 03Milestone definition
Can success be defined objectively?
- 04Capital requirement
How much capital is genuinely required?
- 05Time to evidence
Can the milestone be reached within a sensible financing horizon?
- 06Investment re-underwriting
Does the underlying company still clear Capitaloud's full investment bar?
- 07Structuring decision
Should Capitaloud allocate capital to this opportunity?
- 08Milestone review
Did the expected evidence actually emerge?
Typical syndication
- Find company
- Receive founder deck
- Share opportunity
- Aggregate investor interest
Capitaloud
- Identify company
- Underwrite venture
- Identify evidence gap
- Define milestone
- Assess milestone economics
- Decide whether to invest
- If approved, structure a deal-specific investment vehicle
An identifiable evidence gap is not by itself an investment case. Capitaloud may decline to syndicate an opportunity where the founder, market, terms, milestone economics, risk profile or expected outcome does not justify investment.
What this produces
A scored architecture, not a gut call
Every company is assessed against the same ten dimensions, with weighting applied consistently. The score structures judgement. It does not replace judgement.
Explicit falsification criteria
Every thesis records what would make us wrong. Later reviews compare progress against those original criteria.
A permanent decision record
Investments, passes and holds are date-stamped with reasoning and terms at the time, and never retrospectively altered.